About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Point-Of-Care Molecular Diagnostics Market Size, Growth and Forecast to 2031
Point-Of-Care Molecular Diagnostics Market

Point-Of-Care Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product Type (Analyzers, Test Kit, Bacterial, Fungal, Viral), By Technology (PCR, Genetic sequencing, Hybridization, Micro-array), By End-User (Decentralized laboratories, Hospital, Homecare, Assisted living healthcare facilities) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI682DR
Last Updated : November 21, 2024
Author : Debashree Bora
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Point-Of-Care Molecular Diagnostics Market Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Analyzers
        1. By Value
      3. Test Kit
        1. By Value
      4. Bacterial
        1. By Value
      5. Fungal
        1. By Value
      6. Viral
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. PCR
        1. By Value
      3. Genetic sequencing
        1. By Value
      4. Hybridization
        1. By Value
      5. Micro-array
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Decentralized laboratories
        1. By Value
      3. Hospital
        1. By Value
      4. Homecare
        1. By Value
      5. Assisted living healthcare facilities
        1. By Value
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Analyzers
        1. By Value
      3. Test Kit
        1. By Value
      4. Bacterial
        1. By Value
      5. Fungal
        1. By Value
      6. Viral
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. PCR
        1. By Value
      3. Genetic sequencing
        1. By Value
      4. Hybridization
        1. By Value
      5. Micro-array
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Decentralized laboratories
        1. By Value
      3. Hospital
        1. By Value
      4. Homecare
        1. By Value
      5. Assisted living healthcare facilities
        1. By Value
    5. U.S.
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Analyzers
          1. By Value
        3. Test Kit
          1. By Value
        4. Bacterial
          1. By Value
        5. Fungal
          1. By Value
        6. Viral
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. PCR
          1. By Value
        3. Genetic sequencing
          1. By Value
        4. Hybridization
          1. By Value
        5. Micro-array
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Decentralized laboratories
          1. By Value
        3. Hospital
          1. By Value
        4. Homecare
          1. By Value
        5. Assisted living healthcare facilities
          1. By Value
    6. Canada
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Analyzers
        1. By Value
      3. Test Kit
        1. By Value
      4. Bacterial
        1. By Value
      5. Fungal
        1. By Value
      6. Viral
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. PCR
        1. By Value
      3. Genetic sequencing
        1. By Value
      4. Hybridization
        1. By Value
      5. Micro-array
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Decentralized laboratories
        1. By Value
      3. Hospital
        1. By Value
      4. Homecare
        1. By Value
      5. Assisted living healthcare facilities
        1. By Value
    5. U.K.
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Analyzers
          1. By Value
        3. Test Kit
          1. By Value
        4. Bacterial
          1. By Value
        5. Fungal
          1. By Value
        6. Viral
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. PCR
          1. By Value
        3. Genetic sequencing
          1. By Value
        4. Hybridization
          1. By Value
        5. Micro-array
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Decentralized laboratories
          1. By Value
        3. Hospital
          1. By Value
        4. Homecare
          1. By Value
        5. Assisted living healthcare facilities
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Analyzers
        1. By Value
      3. Test Kit
        1. By Value
      4. Bacterial
        1. By Value
      5. Fungal
        1. By Value
      6. Viral
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. PCR
        1. By Value
      3. Genetic sequencing
        1. By Value
      4. Hybridization
        1. By Value
      5. Micro-array
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Decentralized laboratories
        1. By Value
      3. Hospital
        1. By Value
      4. Homecare
        1. By Value
      5. Assisted living healthcare facilities
        1. By Value
    5. China
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Analyzers
          1. By Value
        3. Test Kit
          1. By Value
        4. Bacterial
          1. By Value
        5. Fungal
          1. By Value
        6. Viral
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. PCR
          1. By Value
        3. Genetic sequencing
          1. By Value
        4. Hybridization
          1. By Value
        5. Micro-array
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Decentralized laboratories
          1. By Value
        3. Hospital
          1. By Value
        4. Homecare
          1. By Value
        5. Assisted living healthcare facilities
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Analyzers
        1. By Value
      3. Test Kit
        1. By Value
      4. Bacterial
        1. By Value
      5. Fungal
        1. By Value
      6. Viral
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. PCR
        1. By Value
      3. Genetic sequencing
        1. By Value
      4. Hybridization
        1. By Value
      5. Micro-array
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Decentralized laboratories
        1. By Value
      3. Hospital
        1. By Value
      4. Homecare
        1. By Value
      5. Assisted living healthcare facilities
        1. By Value
    5. UAE
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Analyzers
          1. By Value
        3. Test Kit
          1. By Value
        4. Bacterial
          1. By Value
        5. Fungal
          1. By Value
        6. Viral
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. PCR
          1. By Value
        3. Genetic sequencing
          1. By Value
        4. Hybridization
          1. By Value
        5. Micro-array
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Decentralized laboratories
          1. By Value
        3. Hospital
          1. By Value
        4. Homecare
          1. By Value
        5. Assisted living healthcare facilities
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Analyzers
        1. By Value
      3. Test Kit
        1. By Value
      4. Bacterial
        1. By Value
      5. Fungal
        1. By Value
      6. Viral
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. PCR
        1. By Value
      3. Genetic sequencing
        1. By Value
      4. Hybridization
        1. By Value
      5. Micro-array
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Decentralized laboratories
        1. By Value
      3. Hospital
        1. By Value
      4. Homecare
        1. By Value
      5. Assisted living healthcare facilities
        1. By Value
    5. Brazil
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Analyzers
          1. By Value
        3. Test Kit
          1. By Value
        4. Bacterial
          1. By Value
        5. Fungal
          1. By Value
        6. Viral
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. PCR
          1. By Value
        3. Genetic sequencing
          1. By Value
        4. Hybridization
          1. By Value
        5. Micro-array
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Decentralized laboratories
          1. By Value
        3. Hospital
          1. By Value
        4. Homecare
          1. By Value
        5. Assisted living healthcare facilities
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Point-Of-Care Molecular Diagnostics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Abaxis
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Roche
    3. Abbott
    4. Danaher
    5. BioMerieux
    6. Sysmex
    7. OraSure Technologies
    8. Bayer
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Molecular Diagnostics Market Size & Trends The global molecular diagnostics market size was valued at USD 14.93 billion in 2023 and is projected to reach USD 33.40 billion by 2032, growing at a CAGR of 9.36% during the forecast period (2024–2032).
Buy Now
Global Report
Point of Care Diagnostics Market Size The global point of care diagnostics market size was valued at USD 44.09 billion in 2023 andis projected to reach USD 78.83 billion by 2032, growing at a CAGR of 6.67% during the forecas
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright . All rights Reserved.